@WHO: The aim of the licence is to facilitate the rapid manufacture and commercialization of @CSIC’s #COVID19 serological test worldwide. The agreement covers all related patents and the biological material necessary for manufacture of the test. 👉https://t.co/0EwiiWiAw8 https://t.co/7EQI3BnPbt

http://twitter.com/WHO
via IFTTT